Table 1.
Patient characteristics and pathological results
| Variable | Value |
|---|---|
| Mean (sd, range): | |
| age, years | 59 (7, 37–80) |
| PSA level, ng/mL | 7.5 (5.3, 1.2–100) |
| n (%): | |
| < 6 | 458 (50) |
| 6–10 | 274 (30) |
| 10.01–20 | 136 (15) |
| 20.01–30 | 17 (2) |
| > 30 | 8 (1) |
| Pathological Gleason score | |
| 2–6 | 337 (37) |
| 3 + 4 | 377 (41) |
| 4 + 3 | 106 (12) |
| 8–10 | 78 (9) |
| ECE | |
| Negative | 678 (74) |
| Positive | 236 (26) |
| SVI | |
| Negative | 857 (94) |
| Positive | 57 (6) |
| LNI | |
| Negative | 892 (98) |
| Positive | 22 (2) |
| SM | |
| Negative | 754 (82) |
| Positive | 160 (18) |
| Median (range) | |
| tumour volume, mL | 1.5 (0.1–87) |
| n (%) | |
| < 0.26 | 95 (10) |
| 0.26–0.50 | 97 (11) |
| 0.51–1.00 | 175 (19) |
| 1.01–2.00 | 187 (21) |
| 2.01–4.00 | 183 (20) |
| > 4.00 | 177 (19) |